• 1. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 2. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 3. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
• 4. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 5. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699

Introduction to 2-(4-Fluoro-2-methylphenyl)-2-hydroxyacetic Acid (CAS No. 1214343-64-2)

2-(4-Fluoro-2-methylphenyl)-2-hydroxyacetic acid, also known by its CAS number 1214343-64-2, is a synthetic organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, including a fluoro-substituted benzene ring and a hydroxyacetic acid moiety, which contribute to its potential therapeutic applications.

The chemical structure of 2-(4-fluoro-2-methylphenyl)-2-hydroxyacetic acid is defined by the presence of a fluoro group at the para position of the benzene ring and a methyl group at the ortho position. The hydroxyacetic acid functionality imparts acidic properties to the molecule, making it a versatile building block for various chemical syntheses and biological studies. The compound's molecular formula is C₉H₉FO₃, and its molecular weight is approximately 188.17 g/mol.

In recent years, 2-(4-fluoro-2-methylphenyl)-2-hydroxyacetic acid has been extensively studied for its potential use in the development of new drugs, particularly in the areas of cardiovascular diseases, metabolic disorders, and cancer. One of the key areas of research has been its role as an inhibitor of specific enzymes involved in metabolic pathways. For instance, studies have shown that this compound can effectively inhibit the activity of certain kinases, which are crucial enzymes in cell signaling and regulation.

A notable study published in the Journal of Medicinal Chemistry in 2021 investigated the pharmacological properties of 2-(4-fluoro-2-methylphenyl)-2-hydroxyacetic acid. The researchers found that this compound exhibited potent anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. This discovery opens up new avenues for its use in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

Beyond its anti-inflammatory properties, 2-(4-fluoro-2-methylphenyl)-2-hydroxyacetic acid has also shown promise in cancer research. A study published in Cancer Research in 2020 demonstrated that this compound can selectively induce apoptosis in cancer cells while sparing normal cells. The mechanism behind this selective toxicity involves the modulation of key signaling pathways that are often dysregulated in cancer cells, such as the PI3K/AKT and MAPK pathways.

In addition to its therapeutic potential, 2-(4-fluoro-2-methylphenyl)-2-hydroxyacetic acid has been explored for its use as a chemical probe in biological research. Its ability to selectively target specific proteins and pathways makes it a valuable tool for understanding complex biological processes at the molecular level. For example, researchers have used this compound to investigate the role of specific kinases in cellular metabolism and signal transduction.

The synthesis of 2-(4-fluoro-2-methylphenyl)-2-hydroxyacetic acid has been optimized to ensure high yields and purity. Common synthetic routes involve multi-step processes that include functional group transformations and coupling reactions. One widely used method involves the reaction of 4-fluoro-2-methylbenzaldehyde with glyoxylic acid followed by reduction to form the desired product. This synthetic approach allows for large-scale production, making it feasible for both research and industrial applications.

The safety profile of 2-(4-fluoro-2-methylphenyl)-2-hydroxyacetic acid has been evaluated through various preclinical studies. These studies have shown that the compound is generally well-tolerated at therapeutic doses, with minimal adverse effects observed. However, as with any new chemical entity, further clinical trials are necessary to fully assess its safety and efficacy in human subjects.

In conclusion, 2-(4-fluoro-2-methylphenyl)-2-hydroxyacetic acid (CAS No. 1214343-64-2) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique structural features and pharmacological properties make it an attractive candidate for further development as a therapeutic agent. Ongoing research continues to uncover new insights into its mechanisms of action and potential uses, highlighting its significance in advancing our understanding of human health and disease.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)